Observed Zepbound price anchor starting_self_pay
Observed Zepbound starting_self_pay at $299/month from Zepbound Savings.
Change timeline
Full change history across tracked products.
Filter by product, severity, or basis to review how the current landscape moved over time.
Results
34
All change events
Change events
Page 2 of 2
Observed Zepbound efficacy anchor company_headline
Observed Zepbound company_headline efficacy anchor at 21% from What Is Zepbound?.
Observed Zepbound efficacy anchor label_absolute
Observed Zepbound label_absolute efficacy anchor at 20.9% from Zepbound Prescribing Information.
Observed headline efficacy anchor
Wegovy injection now has a headline efficacy anchor of 15% at Week 68.
Observed Wegovy HD price anchor maintenance_self_pay
Observed Wegovy HD maintenance_self_pay at $399/month from Novo launch release: Wegovy HD available now nationwide.
Observed Foundayo efficacy anchor regardless of completion
Observed Foundayo regardless of completion efficacy anchor at 11.1% from FDA approves Lilly's Foundayo.
Observed Wegovy HD efficacy anchor efficacy_estimand
Observed Wegovy HD efficacy_estimand efficacy anchor at 20.7% from Novo approval release: Wegovy HD 7.2 mg approved in the US.
Observed Wegovy HD efficacy anchor treatment_regimen_estimand
Observed Wegovy HD treatment_regimen_estimand efficacy anchor at 18.8% from Wegovy Prescribing Information.
Observed label-safe efficacy anchor
Wegovy injection now has a label-safe efficacy anchor of 14.9% at Week 68.
Observed Saxenda efficacy anchor label_post_diet_maintenance
Observed Saxenda label_post_diet_maintenance efficacy anchor at 4.9% from Saxenda Prescribing Information.
Observed Saxenda efficacy anchor label_type2_diabetes
Observed Saxenda label_type2_diabetes efficacy anchor at 5.4% from Saxenda Prescribing Information.
Observed Saxenda efficacy anchor label_primary_obesity
Observed Saxenda label_primary_obesity efficacy anchor at 7.4% from Saxenda Prescribing Information.
Observed Contrave efficacy anchor label_absolute
Observed Contrave label_absolute efficacy anchor at 5.4% from Contrave DailyMed label.
Observed Phentermine efficacy anchor short_term_trial
Observed phentermine short_term_trial efficacy anchor at 9.3% from PMC phentermine 14-week trial.
PreviousNext